A study evaluated serum inhibin concentrations in postmenopausal women with ovarian cancer using the αC inhibin immunofluorometric assay (IFMA) and CA125, demonstrating higher sensitivity and comparable or better specificity than previous methods [75]. This evidence concerns the gene MUC16 and ovarian carcinoma.